Neuralink announces that it has obtained approval from the U.S. FDA to conduct a study on human brain implants.
Neuralink, the brain-implant company led by Elon Musk, announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for its first-in-human clinical trial.